MarketCrew › Terminal › SLVYY
SLVYY — Solvay SA (Stock)
Price: $2.74
· 1 day: +0.37% · 5 days: +1.11% · 1 month: -6.80% · YTD: -12.46%
As of 2026-10-09 18:29 UTC.
52-week range: $2.59 – $3.38 (currently at 19% of the range).
The read
SLVYY is in a downtrend, momentum firm. $2.89 is the level overhead; $2.67 the first support below.
4 of 6 technical checks lean bearish.
Price vs 50-day: below Price vs 200-day: below 50d vs 200d avg: below MACD: bullish RSI momentum: 34 5-day tape: +1.1%
Trend Downtrend · below 50-day & below 200-day Momentum RSI 34.29 · neutral · MACD bullish Trend strength ADX 24.4 · developing Location -5.6% vs 50-day MA 52-week range -18% from high · +3% from low Volatility ATR 0.05 · ~1.8%/day
Key levels
Level Type Distance
$2.89 (resistance) swing zone 5.47% $3.0 (resistance) round 9.49% $3.02 (resistance) sma 200 10.22%
$2.67 (support) 52w low -2.55% $2.5 (support) round -8.76% $2.0 (support) round -27.01%
Indicators
RSI (14) 34.29 MACD -0.0558
ADX (14) 24.4 ATR (14) 0.05
50-day average $2.9 200-day average $3.02
Next earnings: 2025-07-29.
Latest SLVYY news
Emulsifiers Market worth $18.15 billion by 2031 - Exclusive Report by MarketsandMarkets™ — According to MarketsandMarkets™, the global emulsifiers market is projected to reach USD 18.15 billion by 2031, growing from USD 12.15 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The market growth is (PR Newswire, 2026-10-02) Global Engineering Plastics Market to Reach USD 300 Bn. by 2034 at 7.4% CAGR as EV Lightweighting, Advanced Electronics and High-Performance Polymer Demand Accelerate Growth Maximize Market Research — The global engineering plastics market was valued at USD 125.10 billion in 2025 and is projected to grow at a CAGR of 7.4% from 2026 to 2034, reaching nearly USD 300 billion by 2034, according to Maximize Market Research (PR Newswire, 2026-09-30) European industry is doing better than you may think — European industry faces concentrated pressure from high energy costs and Chinese competition, particularly affecting chemicals and automotive sectors, with Chinese trade surplus reaching $420 billion. However, the damage (The Economist, 2026-09-27) China's stranglehold on rare earths must be ended, says hopeful supplier to EU — China's rare earth export controls, first imposed in April 2025, have created market nervousness ahead of the Trump-Xi summit, with industry leaders hoping for an extension of a 12-month suspension. China controls 80-90% (The Guardian, 2026-09-20) Medical Polymer Market worth $71.92 billion by 2031 - Exclusive Report by MarketsandMarkets™ — The global medical polymer market is projected to grow from USD 48.27 billion in 2026 to USD 71.92 billion by 2031, representing a compound annual growth rate (CAGR) of 8.3%. Growth drivers include increasing demand for (PR Newswire, 2026-09-17) EXCLUSIVE: Solvay in talks with One Investment Management on rare earths partnership — Solvay, the Belgian chemicals group, confirmed it is in talks with One Investment Management (OneIM) about a potential strategic partnership for its rare earths business. The discussions, ongoing since March, would give (Reuters, 2026-09-08) Brazil Funds Rare-Earth Project in Effort to Tap Vast Reserves — Viridian Mining and Minerals Ltd. has secured 77.5 million Brazilian reals ($15 million) in funding from Brazil's development bank BNDES for a rare-earth research center project. The initiative represents Brazil's strate (Bloomberg Business, 2026-09-08) Potassium Fluoride Market worth $0.51 billion by 2032 - Exclusive Report by MarketsandMarkets™ — The global potassium fluoride market is projected to grow from USD 0.43 billion in 2026 to USD 0.51 billion by 2032, representing a compound annual growth rate (CAGR) of 2.9% during the forecast period. Growth is driven (PR Newswire, 2026-09-03)
Explore more
Interactive SLVYY chart and analyst chat ·
Market terminal — movers, signals and news ·
Use MarketCrew inside Claude ·
Use MarketCrew inside ChatGPT ·
Top gainers today ·
52-week highs
MarketCrew provides automated, informational market analysis — research & education,
not investment advice or a recommendation to buy or sell any security. © MarketCrew ·
Privacy · Terms